Numeric Investors’s Neurogene NGNE Stock Holding History

Numeric Investors’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,291	Closed	-$2.32M	–	1085
2015 Q4	$2.32M	Buy	+9,291	New	+$2.44M	0.02%	417

Other funds holding NGNE

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors's NGNE Position: Q1 2016 in Review

Numeric Investors sold out of Neurogene (NGNE) in Q1 2016, closing a stake of 9,291 shares — an estimated $2.32M sold.

Numeric Investors first reported a position in NGNE in Q4 2015 and held it in 1 quarter. The position peaked at $2.32M in Q4 2015. 35 funds tracked by Wall St. Rank hold NGNE as of Q1 2016.

Numeric Investors reported no remaining Neurogene position as of Q1 2016 after selling out during the quarter.
Numeric Investors sold 9,291 Neurogene shares in Q1 2016, an estimated $2.32M.
Numeric Investors first reported a position in Neurogene in Q4 2015 and held it in 1 quarter.
Numeric Investors's Neurogene position peaked at $2.32M in Q4 2015.
35 funds tracked by Wall St. Rank held Neurogene as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.